Newsletter | November 23, 2022

11.23.22 -- Powering Innovation In Cell And Gene Therapy

 
Navigating The Path To The Clinic And Beyond For Gene Therapies
 

A gene therapy’s path from the research lab to the clinic and, ultimately, the market requires manufacturing processes that will meet the regulatory requirements and logistics to get therapies to clinical trial sites.

Radiance Label-Free Monitoring Of AAV Transfection In HEK293 Cells
 

Improve the characterization of cell-based AAV transfection and production, increase the efficiency and accuracy of both processes, and shorten development time.

Technology Integrators In Cell And Gene Therapy: Powering Innovation
 

Accelerated clinical trial timelines for advanced therapeutics are on the rise. With Fast Track designations, it is increasingly critical for innovators to have efficient and scalable production processes.

The Journey Into Cell And Gene Therapy
 

Hear about Catalent's venture into the development and manufacturing of viral vector gene therapies and how we are overcoming challenges and maintaining our commitment to our partners.